Skip to main content

Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1403))

Abstract

Rabies is a viral infection of the central nervous system for which vaccination is the only treatment possible. Besides preexposure, vaccination is highly recommended for people living in endemic areas, veterinarians, and laboratory workers. Our group has developed rabies virus-like particles (RV-VLPs) with immunogenic features expressed in mammalian cells for vaccine applications. In this chapter the methods to obtain and characterize a stable HEK293 cell line expressing RV-VLPs are detailed. Further, analytical ultracentrifugation steps to purify the obtained VLPs are developed, as well as western blot, dynamic light scattering, and immunogold electron microscopy to analyze the size, distribution, shape, and antigenic conformation of the purified particles. Finally, immunization protocols are described to study the immunogenicity of RV-VLPs.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Yousaf MZ, Qasim M, Zia S, Khan MR, Ashfaq UA, Khan S (2012) Rabies molecular virology, diagnosis, prevention and treatment. Virol J 9:50

    Article  PubMed  PubMed Central  Google Scholar 

  2. Schnell MJ, McGettigan JP, Wirblich C, Papaneri A (2010) The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol 8:51–61

    CAS  PubMed  Google Scholar 

  3. Gautret P, Parola P (2012) Rabies vaccination for international travelers. Vaccine 30:126–133

    Article  PubMed  Google Scholar 

  4. Meslin FX, Briggs DJ (2013) Eliminating canine rabies, the principal source of human infection: what will it take? Antivir Res 98:291–296

    Article  CAS  PubMed  Google Scholar 

  5. World Health Organization (2013). WHO expert consultation on rabies. Second report. World Health Organ Tech Rep Ser 982

    Google Scholar 

  6. Ertl HC (2009) Novel vaccines to human rabies. PLoS Negl Trop Dis 3(9):e515

    Article  PubMed  PubMed Central  Google Scholar 

  7. Yang DK, Kim HH, Lee KW, Song JY (2013) The present and future of rabies vaccine in animals. Clin Exp Vaccine Res 2:19–25

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Noad R, Roy P (2003) Virus-like particles as immunogens. Trends Microbiol 11:438–444

    Article  CAS  PubMed  Google Scholar 

  9. Roldão A, Mellado MCM, Castilho LR, Carrondo MJT, Alves PM (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9(10):1149–1176

    Article  PubMed  Google Scholar 

  10. Lua LHL, Connors NK, Sainsbury F, Chuan YP, Wibowo N, Middelberg APJ (2014) Bioengineering virus-like particles as vaccines. Biotechnol Bioeng 111:425–440

    Article  CAS  PubMed  Google Scholar 

  11. Fontana D, Kratje R, Etcheverrigaray M, Prieto C (2014) Rabies virus-like particles expressed in HEK293 cells. Vaccine 32:2799–2804

    Article  CAS  PubMed  Google Scholar 

  12. Wu CY, YehYC YYC, Chou C, Liu MT, Wu HS, Chan JT, Hsiao PW (2010) Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus. Plos One 5(3):e784

    Article  Google Scholar 

  13. Chuan Li C, Liu F, Liang M, Zhang Q, Wang X, Wang T, Li J, Li D (2010) Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice. Vaccine 28:4294–4300

    Article  PubMed  Google Scholar 

  14. Hua RH, Li YN, Chen ZS, Liu LK et al (2014) Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate. BMC Biotechnol 14:62

    Article  PubMed  PubMed Central  Google Scholar 

  15. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463–8471

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267

    Article  CAS  PubMed  Google Scholar 

  17. Picanço-Castro V, Fontes AM, de Sousa Russo-Carbolante EM, Covas DR (2008) Lentiviral-mediated gene transfer – a patent review. Expert Opin Ther Pat 18(5):1–15

    Article  Google Scholar 

  18. Federico M (ed) (2010) Lentivirus gene engineering protocols. 2nd edition. Methods in Molecular Biology, Vol. 614. Humana, UK

  19. Zeltins A (2012) Construction and characterization of virus-like particles: a review. Mol Biotechnol 53:92–107

    Article  Google Scholar 

  20. Wilbur LA, Aubert MFA (1996) The NIH potency test. In: Meslin FX, Kaplan MM, Koprowsky H (eds) Laboratory techniques in rabies. WHO, Geneva, Switzerland, pp 360–366

    Google Scholar 

  21. Prieto C, Fontana D, Etcheverrigaray M, Kratje R (2011) A strategy to obtain recombinant cell lines with high expression levels. Lentiviral vector-mediated transgenesis. BMC Proc 5(8):P7

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Juan Pablo Soto (Institutional Image, Universidad Nacional del Litoral, Argentina) for technical support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Diego Fontana .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this protocol

Cite this protocol

Fontana, D., Etcheverrigaray, M., Kratje, R., Prieto, C. (2016). Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 1403. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3387-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3387-7_7

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-3385-3

  • Online ISBN: 978-1-4939-3387-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics